Synova And BioPad, Ltd. Complete Development Of Data Logging System For Non-Invasive Fetal Monitor

MEDIA, Pa., March 23 /PRNewswire-FirstCall/ -- Synova Pre-Natal Healthcare, Inc., a subsidiary of Synova Healthcare Group, Inc. , and BioPad, Ltd. have successfully completed the development and testing of a data logging system for use with their non- invasive fetal monitor, under joint development by the companies. The device provides a non-invasive means of monitoring fetal movement during the last trimester of pregnancy. Integral to the further development and marketing of the non-invasive fetal monitor is the ability to collect and integrate data from multiple sources including ultrasound. Successful development of a data logging system for the product will enable Synova to rapidly progress this non-invasive diagnostic device to market.

"This is an important achievement for the BioPad-Synova research team," stated Dr. Ron Spangler, PhD, Chief Scientific Officer, Synova Healthcare Group, Inc. "Validation of a data logging system will provide a means to test a variety of algorithms for detecting fetal movement. In addition, a data logging system will facilitate completion of ongoing trials and accelerate clinical development of this device in the United States.

"The product is intended to provide women with added assurance that their fetus is developing normally," reiterated Dr. Spangler. "Achievement of this milestone brings this device a step closer to market, and furthers Synova's mission to provide consumers with safe, effective and inexpensive means of assessing their health status."

About Synova Healthcare Group, Inc.:

Synova Healthcare Group, Inc. presently operates two wholly owned subsidiaries: Synova Healthcare, Inc. and Synova Pre-Natal Healthcare, Inc. The company distributes rapid, non-invasive medical diagnostics to retail for over-the-counter (OTC) use, and directly to health care providers for point of care (POC) use in the clinical setting. The company's products are designed to improve human health and quality of life by providing early and accurate awareness of the onset of certain medical conditions.

This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. Such risk factors are discussed in the Company's Form SB-2 registration statement (File No. 333-123498), filed with the Securities and Exchange Commission on August 10, 2005, as well as in periodic reports filed with the Commission. There can be no assurance that such factors will not affect the accuracy of such forward-looking statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information set forth in this Press Release including such forward-looking statements. This Press Release does not constitute an offer to sell or the solicitation of an offer to buy; nor will there be any sale of securities of Synova Healthcare Group, Inc. in any state where such offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of those states.

Corporate Contact Information: Synova Healthcare Group, Inc. Attn: Mr. Robert Edwards, CFO 1400 N. Providence Road, Ste. 6010 Media, PA 19063 Tel: 610-565-7080 Fax: 610-565-7081 http://www.synovahealthcare.com Inquiries may also be directed to: info@synovahealthcare.com

Synova Healthcare Group, Inc.

CONTACT: Mr. Robert Edwards, CFO, Synova Healthcare Group, Inc.,+1-610-565-7080, Fax: +1-610-565-7081, or Inquiries may also be directedto: info@synovahealthcare.com

MORE ON THIS TOPIC